Lonza Group AG Lonza Group AG

Lonza Group AG

LONN

Clasificación en acciones #447
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Precio por acción
$764.04
Capitalización bursátil
$53.36B
Cambio (1 día)
0.96%
Cambio (1 año)
8.59%
País
CH
Comercio Lonza Group AG (LONN)

Categoría

Healthcare
Historial de desdoblamientos de acciones de Lonza Group AG (LONN)
La acción Lonza Group AG (símbolo: LONN) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Oct 22, 2026.
Una acción LONN comprada antes de Oct 22, 2026 equivaldría hoy a 0 acciones LONN.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
US
1 x3
AU
0 -
NL
1 x100
BE